Survivin: a target from brain cancer to neurodegenerative disease.
about
Survivin Is a transcriptional target of STAT3 critical to estradiol neuroprotection in global ischemiaSurvivin mutant protects differentiated dopaminergic SK-N-SH cells against oxidative stress.Nanoformulated cell-penetrating survivin mutant and its dual actions.Divergent modulation of neuronal differentiation by caspase-2 and -9.(-)-Epigallocatechin-3-gallate modulates spinal cord neuronal degeneration by enhancing growth-associated protein 43, B-cell lymphoma 2, and decreasing B-cell lymphoma 2-associated x protein expression after sciatic nerve crush injury.Lipid-conjugated Smac analogues.Chronic exposure to cerebrospinal fluid of multiple system atrophy in neuroblastoma and glioblastoma cells induces cytotoxicity via ER stress and autophagy activationProtection effect of survivin protein overexpression on acute myocardial infarction in rats.The dual behavior of PCSK9 in the regulation of apoptosis is crucial in Alzheimer's disease progression (Review).Chimeric aptamers in cancer cell-targeted drug deliverySurvivin signaling in clinical oncology: a multifaceted dragon.Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy.Upregulating the Expression of Survivin-HBXIP Complex Contributes to the Protective Role of IMM-H004 in Transient Global Cerebral Ischemia/Reperfusion.Bayesian Analysis of MicroScale Thermophoresis Data to Quantify Affinity of Protein:Protein Interactions with Human Survivin.Recent advances in nanomedicine and survivin targeting in brain cancers.
P2860
Q28573165-0778F2D3-F58F-4C1D-B0A9-55C4DB363FE6Q33798063-62210DEA-79D2-4966-AB08-91090DB972FFQ33904982-751CCD80-CDD1-4B87-B2DA-08DA575301E2Q34281577-06283D2B-8CC5-4A35-9ABB-825176CCFE7BQ34983883-9BD1BD75-F411-483B-9070-964C5C73D97FQ35780628-864C8746-E2D6-4622-B820-F64992A40BF1Q35955278-71B21C04-6E4C-49CA-BD9E-BA0E5E3D9F96Q36182887-E7E2BB7E-0811-4AD3-96DF-6030E8E76585Q37567746-87D01C0E-67A1-4F5B-80E2-F988E073E04FQ37939984-92638D82-E4A2-4AC8-9A83-DE6D1C8876B6Q38017923-8737734A-5878-4975-BF05-904202EF525BQ38021661-BB461D04-6254-462A-A69F-5F9835857D6AQ39596768-DECD8185-C42E-464D-AF5D-E150DCA04790Q40342576-247AC7E8-6B9A-4D1C-8B13-FF431F7F1764Q45943350-07A2A44E-99AA-4410-A329-81C02597A2D8Q47378913-7CD32C8B-10AD-4B3A-959E-92DA7F9AD60F
P2860
Survivin: a target from brain cancer to neurodegenerative disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Survivin: a target from brain cancer to neurodegenerative disease.
@en
Survivin: a target from brain cancer to neurodegenerative disease.
@nl
type
label
Survivin: a target from brain cancer to neurodegenerative disease.
@en
Survivin: a target from brain cancer to neurodegenerative disease.
@nl
prefLabel
Survivin: a target from brain cancer to neurodegenerative disease.
@en
Survivin: a target from brain cancer to neurodegenerative disease.
@nl
P2860
P1476
Survivin: a target from brain cancer to neurodegenerative disease
@en
P2093
Rupinder K Kanwar
P2860
P304
P356
10.3109/10409238.2010.516740
P577
2010-10-07T00:00:00Z